Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO-System.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing preclinical mechanisms and animal studies without human clinical data
PubMed 40573323 · doi:10.3390/ph18060928
What was done
This narrative review summarizes preclinical and mechanistic literature on the cytoprotective actions, safety profile, and therapeutic potential of stable gastric pentadecapeptide BPC 157. The authors examine its modulation of angiogenesis and nitric oxide system pathways across tissue healing, in vitro and in vivo tumor models, and rodent models of neurodegenerative conditions.
What was found
The abstract reports no numerical data, sample sizes, or statistical effect estimates. It qualitatively describes that BPC 157 achieves high safety in animal models without reaching an LD1, modulates angiogenesis without inducing pathological corneal neovascularization, regulates nitric oxide levels while reducing free radical formation, demonstrates anti-tumor effects in vitro and in vivo, and attenuates disease-like features in mouse and rat models of Parkinson's and Alzheimer's diseases.
Why it matters
The paper outlines theoretical and preclinical arguments for BPC 157 as a pleiotropic regulator of angiogenesis and nitric oxide signaling during tissue injury.
Limits
The review relies entirely on mechanistic reasoning, cell culture experiments, and animal models, with no human clinical trial data presented. The abstract reports no quantitative measurements or confidence intervals. Animal model outcomes and broad cytoprotective claims cannot be assumed to translate to clinical efficacy or safety in humans.
Cited by
- supports Published animal literature on BPC-157 shows no signal of increased cancer or tumorigenesis.
- supports The vast majority of published animal research literature on BPC-157 originates from Dr. Predrag Sikiric's research group in Croatia.